Early-stage ovarian squamous cell carcinoma arising in a mature cystic teratoma

This ovarian cancer diagnosis at a glance

Stage at diagnosis
Stage I
Subtype
Squamous Cell Carcinoma
Biomarkers
ovarian tumor HPV DNA-negative; p16-negative
Sex
female
Treatment
surgery and chemotherapy
Outcome
Cancer-Free / NED

Treatment course, step by step

  1. Underwent comprehensive staging surgery including hysterectomy, bilateral salpingo-oophorectomy, omentectomy and lymph-node dissection.
  2. Completed 4 cycles of paclitaxel plus carboplatin.

What happened, in summary

A 58-year-old postmenopausal woman was found to have a large left ovarian mass after two months of lower abdominal pain. Surgery and pathology showed a rare Stage I squamous cell carcinoma arising within a mature cystic teratoma. The cancer was confined to the ovary, lymph nodes were negative and peritoneal washings showed no malignant cells. She underwent comprehensive staging surgery, including hysterectomy, removal of both ovaries and fallopian tubes, omentectomy and lymph-node dissection. Because of the large tumor and challenges with close surveillance, she then completed four cycles of paclitaxel and carboplatin chemotherapy. Cervical testing also found high-risk HPV and a low-grade cervical lesion, but there was no invasive cervical cancer. Testing of the ovarian cancer itself was HPV DNA-negative and p16-negative, supporting an ovarian origin rather than spread from the cervix. She achieved complete remission after treatment. At her most recent follow-up in June 2026, 24 months after surgery, there was no evidence of ovarian-cancer recurrence.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

Similar ovarian cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more ovarian cancer stories